Donor anti-Jka causing hemolysis in a liver transplant recipient

被引:27
作者
Hareuveni, M
Merchav, H
Austerlitz, N
Rahimi-Leveen, N
Ben-Tal, O
机构
[1] Sourasky Med Ctr, Blood Bank, IL-64239 Tel Aviv, Israel
[2] Asaff Harofeh Med Ctr, Zerifin, Israel
关键词
D O I
10.1046/j.1537-2995.2002.00075.x
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
BACKGROUND: Hemolytic transfusion reactions have been observed in recipients of ABO- and/or D-mismatched marrow, peripheral blood, and solid organs. Passenger lymphocyte syndrome occurs when immunocompetent donor lymphocytes transferred during transplantation produce alloantibodies against host antigens. CASE REPORT: The first case of a delayed, anti-Jk(a)-mediated hemolytic reaction in a liver transplant recipient, caused by passenger donor lymphocytes, is reported here. A 43-year-old man underwent liver transplantation. Six weeks later, the patient underwent a second liver transplant. On Day 10 of the second transplant, clinical hemolysis ensued; anti-Jk(a) was detected. The patient's DAT became positive, and anti-Jk(a) was eluted from his RBCs. On Day 35 of the patient's second transplant, 3 weeks after the last blood transfusion, the patients' DAT was still weakly positive with anti-Jk(a) in the eluate. Six months later, serum antibody screening was negative, but the DAT was still weakly positive. The patient's RBCs tested Jk(a+), whereas the second donor's RBCs were Jk(a-). CONCLUSION: This is the first documentation of clinically significant hemolysis caused by anti-Jk(a), produced by passenger lymphocytes transferred from the donor's liver to the transplant recipient.
引用
收藏
页码:363 / 367
页数:5
相关论文
共 33 条
[1]
Rapid engraftment after allogeneic ABO-incompatible peripheral blood progenitor cell transplantation complicated by severe hemolysis [J].
Bornhauser, M ;
Ordemann, R ;
Paaz, U ;
Schuler, U ;
Kompf, J ;
Holig, K ;
Ehninger, G .
BONE MARROW TRANSPLANTATION, 1997, 19 (03) :295-297
[2]
DELAYED HEMOLYSIS RESULTING FROM ANTI-A1 AFTER LIVER-TRANSPLANTATION [J].
BRECHER, ME ;
MOORE, SB ;
REISNER, RK ;
RAKELA, J ;
KROM, RAF .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1989, 91 (02) :232-235
[3]
RED-CELL ALLOANTIBODY DEVELOPMENT ASSOCIATED WITH HEART AND LUNG TRANSPLANTATION [J].
CUMMINS, D ;
CONTRERAS, M ;
AMIN, S ;
HALIL, O ;
DOWHAM, B ;
YACOUB, MH .
TRANSPLANTATION, 1995, 59 (10) :1432-1435
[4]
Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation.: Is ABO incompatibility a predisposing factor? [J].
de la Rubia, A ;
Arriaga, F ;
Andreu, R ;
Sanz, G ;
Jiménez, C ;
Vicente, A ;
Carpio, N ;
Marty, ML ;
Sanz, MA .
TRANSFUSION, 2001, 41 (01) :106-110
[5]
Elhence P, 1998, J NEPHROL, V11, P40
[6]
HOWS J, 1986, BLOOD, V67, P177
[7]
INDUCTION OF RED BLOOD-CELL DESTRUCTION BY GRAFT-DERIVED ANTIBODIES AFTER MINOR ABO-MISMATCHED HEART AND LUNG TRANSPLANTATION [J].
HUNT, BJ ;
YACOUB, M ;
AMIN, S ;
DEVENISH, A ;
CONTRERAS, M .
TRANSPLANTATION, 1988, 46 (02) :246-249
[8]
Jacobs LB, 1996, ARCH PATHOL LAB MED, V120, P684
[9]
IMMUNE-MEDIATED CYTOPENIA FOLLOWING BONE-MARROW TRANSPLANTATION - CASE-REPORTS AND REVIEW OF THE LITERATURE [J].
KLUMPP, TR ;
BLOCK, CC ;
CALIGIURI, MA ;
RABINOWE, SN ;
SOIFFER, RJ ;
RITZ, J .
MEDICINE, 1992, 71 (02) :73-83
[10]
KLUMPP TR, 1991, BONE MARROW TRANSPL, V8, P159